5 Most Undervalued Healthcare Stocks to Buy Now

In this article, we will be taking a look at the 5 most undervalued healthcare stocks to buy now. If you wish to see the full list and how we came up with these stocks, visit 9 Most Undervalued Healthcare Stocks to Buy Now.

15 States with the Best Healthcare in the US

5. Inspire Medical Systems, Inc. (NYSE:INSP)

PE Ratio: 10.64

Inspire Medical Systems, Inc. (NYSE:INSP) is among the most undervalued stocks to invest in.

TheFly reported on April 15 that Truist Financial reduced its price target for INSP from $70 to $64 while maintaining a Hold stance on the stock. The adjustment was made within a broader outlook on MedTech ahead of first-quarter results, with expectations that performance may meet or slightly exceed cautious investor sentiment around procedure volumes. However, the firm noted that the current valuation discount versus peers appears warranted due to near-term growth uncertainty, particularly linked to slowing domestic expansion and ongoing reimbursement-related challenges.

Similarly, a day earlier on April 14, Royal Bank of Canada revised its outlook on Inspire Medical Systems, Inc. (NYSE:INSP) and lowered its price target from $68 to $56 while maintaining a Sector Perform rating. This update also came as part of a broader MedTech sector review ahead of first-quarter earnings. Despite acknowledging stable underlying demand conditions and generally solid fundamentals with no signs of major market disruption, the firm highlighted that recent sentiment-driven weakness may be overstated. At the same time, it pointed to operational pressures affecting utilization and new center growth, including reimbursement coding challenges and delayed patient progression related to GLP-1 therapy trends, which limit near-term visibility across upcoming quarters.

In separate news, Inspire Medical Systems, Inc. (NYSE:INSP) will report its Q1 2026 results on May 4.

Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company based in Minneapolis that develops implantable neurostimulation therapy for obstructive sleep apnea. It’s an FDA-approved device that stimulates the hypoglossal nerve as an alternative to CPAP treatment.